Regional Overview of Executive Summary Lung Cancer Liquid Biopsy Market by Size and Share
CAGR Value
Data Bridge Market Research analyses that the lung cancer liquid biopsy market which was USD 0.30 billion in 2022, is expected to reach USD 1.38 billion by 2030, at a CAGR of 21% during the forecast period 2023 to 2030.
The market report also contains the drivers and restraints...
Lung Cancer Surgery Market Summary:
According to the latest report published by Data Bridge Market Research, the Lung Cancer Surgery Market
CAGR Value
This global Lung Cancer Surgery Market report is a wonderful guide to achieve an information or key data about market, emerging trends, product usage, motivating factors for customers, competitor strategies, brand...
According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...
According to a newly published market research report by 24LifeSciences, the global MET inhibitors for lung cancer market was valued at USD 1.1 billion in 2024 and is projected to reach USD 2.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252032.
MET inhibitors represent a breakthrough class of targeted cancer therapies...
NEWARK, DE | The lung cancer surgery market stands at USD 1.6 billion in 2026 and is forecast to reach USD 2.8 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.9%. This sustained expansion reflects the critical role of surgical intervention in oncology, particularly for resectable early-stage non-small cell lung cancer (NSCLC), where...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek